High risk neuroblastoma: a persistent therapeutic challenge

Pediatr Blood Cancer. 2008 Dec;51(6):722-3. doi: 10.1002/pbc.21754.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Combined Modality Therapy
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Neuroblastoma / drug therapy
  • Neuroblastoma / therapy*
  • Risk Factors
  • Treatment Outcome